Financials 1933 Industries Inc.

Equities

QF

CA65442F1053

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:03:09 2024-04-26 pm EDT 5-day change 1st Jan Change
0.015 CAD 0.00% Intraday chart for 1933 Industries Inc. -25.00% 0.00%

Valuation

Fiscal Period: Juli 2018 2019 2020 2021 2022 2023
Capitalization 1 87.43 115.3 19.76 40.53 11.27 6.919
Enterprise Value (EV) 1 84.38 120.7 42.74 53.99 28.59 23.4
P/E ratio -12.9 x -5.5 x -0.86 x -5.38 x -0.63 x -0.51 x
Yield - - - - - -
Capitalization / Revenue 6.91 x 6.39 x 1.65 x 3.38 x 0.9 x 0.38 x
EV / Revenue 6.67 x 6.68 x 3.57 x 4.51 x 2.28 x 1.28 x
EV / EBITDA -33.6 x -12.8 x -2.64 x -15.6 x -7.17 x -2.67 x
EV / FCF -8.51 x -5.72 x -5.16 x -16.2 x -4.76 x 9.42 x
FCF Yield -11.7% -17.5% -19.4% -6.17% -21% 10.6%
Price to Book 2.39 x 3.08 x 0.98 x 1.56 x 1.32 x -1.87 x
Nbr of stocks (in thousands) 227,093 281,282 303,945 450,327 450,699 461,234
Reference price 2 0.3850 0.4100 0.0650 0.0900 0.0250 0.0150
Announcement Date 11/28/18 11/28/19 11/30/20 11/29/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juli 2018 2019 2020 2021 2022 2023
Net sales 1 12.65 18.06 11.96 11.98 12.54 18.27
EBITDA 1 -2.514 -9.428 -16.16 -3.455 -3.985 -8.763
EBIT 1 -2.793 -9.968 -16.63 -3.62 -5.018 -9.644
Operating Margin -22.08% -55.2% -139.04% -30.23% -40.02% -52.78%
Earnings before Tax (EBT) 1 -4.312 -19.65 -20.15 -5.805 -17.52 -13.44
Net income 1 -5.729 -18.79 -21.54 -6.47 -17.81 -13.36
Net margin -45.29% -104.03% -180.08% -54.03% -142.02% -73.13%
EPS 2 -0.0298 -0.0745 -0.0752 -0.0167 -0.0395 -0.0293
Free Cash Flow 1 -9.913 -21.1 -8.287 -3.33 -6 2.483
FCF margin -78.36% -116.81% -69.28% -27.81% -47.85% 13.59%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/28/18 11/28/19 11/30/20 11/29/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 - 5.34 23 13.5 17.3 16.5
Net Cash position 1 3.05 - - - - -
Leverage (Debt/EBITDA) - -0.5667 x -1.422 x -3.897 x -4.346 x -1.88 x
Free Cash Flow 1 -9.91 -21.1 -8.29 -3.33 -6 2.48
ROE (net income / shareholders' equity) -20.7% -50% -70.7% -28.1% -110% -1,236%
ROA (Net income/ Total Assets) -5.8% -12.1% -19.2% -4.92% -8.43% -25.6%
Assets 1 98.86 155.3 112.1 131.4 211.1 52.14
Book Value Per Share 2 0.1600 0.1300 0.0700 0.0600 0.0200 -0.0100
Cash Flow per Share 2 0.0200 0.0600 0.0100 0.0100 0 0
Capex 1 3.74 17.1 1.1 0.46 0.01 0.8
Capex / Sales 29.6% 94.68% 9.16% 3.81% 0.12% 4.39%
Announcement Date 11/28/18 11/28/19 11/30/20 11/29/21 11/28/22 11/28/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. QF Stock
  4. Financials 1933 Industries Inc.